Melanocytic Neoplasm — Trials

Melanocytic Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,258 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 151–200 of 3,258 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02224781	Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma	active not recruiting	Phase 3	267	National Cancer Institute (NCI)NIH	1	Aug 28, 2026	clinicaltrials
NCT02339571	A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma	active not recruiting	Phase 2 / Phase 3	600	National Cancer Institute (NCI)NIH	1	Aug 28, 2026